Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T15:35:58.799Z.
Calculation as of: 2026-10-06T15:35:58.799Z.
Quote observation: 2026-10-06T15:34:22.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 396f74b358d2be52688229160785b883c1ccba5e7e57b4b59ce0869c705c56f9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$401.26M
Operating Cash Flow Yield
1.92%
TTM Avg
1.03%
3Y Avg
1.03%
5Y Avg
0.91%
Market Cap
$395.51M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$409.89M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$414.54M
Operating Cash Flow Yield
N/A
TTM Avg
24.51%
3Y Avg
24.51%
5Y Avg
24.51%
Market Cap
$389.09M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$418.06M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$384.41M
Operating Cash Flow Yield
4.44%
TTM Avg
6.07%
3Y Avg
5.74%
5Y Avg
4.65%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Carlsmed, Inc. (CARL) | $402.07M | N/A | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $401.26M | 1.92% | 1.03% | 1.03% | 0.91% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $395.51M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $409.89M | N/A | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $414.54M | N/A | 24.51% | 24.51% | 24.51% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $389.09M | N/A | N/A | N/A | N/A |
| Neurogene Inc. (NGNE)vs › | $415.76M | N/A | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $418.06M | N/A | N/A | N/A | N/A |
| Orthofix Medical Inc. (OFIX)vs › | $384.41M | 4.44% | 6.07% | 5.74% | 4.65% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $379.87M | N/A | 14.06% | 11.48% | 11.48% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
